 | Five Prime Therapeutics (NASDAQ:FPRX) Upgraded to Hold by Zacks Investment Research
marketbeat.com - January 19 at 4:52 AM |
 | Five Prime Therapeutics (NASDAQ:FPRX) Trading 7.1% Higher
americanbankingnews.com - January 22 at 7:18 PM |
| Five Prime Therapeutics (NASDAQ:FPRX) Stock Price Down 6.8%
americanbankingnews.com - January 21 at 8:22 PM |
| Short Interest in Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Expands By 26.8%
americanbankingnews.com - January 17 at 10:44 AM |
| Five Prime Therapeutics (NASDAQ:FPRX) Shares Gap Up to $15.96
americanbankingnews.com - January 15 at 12:04 PM |
 | Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ Gastric and GEJ Cancers
finance.yahoo.com - January 15 at 8:34 AM |
| Five Prime Therapeutics (NASDAQ:FPRX) Stock Price Up 6.7%
americanbankingnews.com - January 14 at 9:29 PM |
| Five Prime Therapeutics (NASDAQ:FPRX) Stock Price Down 7.6%
americanbankingnews.com - January 12 at 9:51 PM |
| Five Prime Therapeutics (NASDAQ:FPRX) Trading 5% Higher
americanbankingnews.com - January 8 at 7:42 PM |
 | Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo?
prnewswire.com - January 5 at 10:09 AM |
|
| We're Hopeful That Five Prime Therapeutics (NASDAQ:FPRX) Will Use Its Cash Wisely
finance.yahoo.com - December 21 at 9:31 AM |
| Is FPRX A Good Stock To Buy Now?
finance.yahoo.com - December 18 at 12:38 AM |
 | Five Prime Therapeutics: Understanding Bemarituzumab
seekingalpha.com - December 11 at 10:27 PM |
| Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Virtual Annual Symposium
finance.yahoo.com - December 9 at 6:04 PM |
 | Why Five Prime Therapeutics Stock Gained 312% in November
fool.com - December 8 at 10:08 AM |
| Five Prime Therapeutics: Primed For Growth
seekingalpha.com - December 4 at 9:01 AM |
| Five Prime Announces Closing of Upsized Public Offering of Common Stock
finance.yahoo.com - November 17 at 8:03 PM |
| Five Prime prices upsized equity offering at $21
seekingalpha.com - November 13 at 7:44 AM |
 | Why Five Prime Therapeutics Stock Is Trading Higher Today
benzinga.com - November 13 at 1:10 AM |
| Five Prime Announces Pricing of Upsized Public Offering of Common Stock
finance.yahoo.com - November 13 at 1:10 AM |
| Small Biotech Five Prime Launches For A Second Day Running — Here's Why
finance.yahoo.com - November 12 at 3:09 PM |
| Five Prime shares rise 14% as anti-CCR8 antibody FPA157 shows promising effect
seekingalpha.com - November 12 at 10:09 AM |
| Are Options Traders Betting on a Big Move in Five Prime (FPRX) Stock?
finance.yahoo.com - November 12 at 10:09 AM |
| Is Five Prime Stock a Buy Right Now? This Is What You Need To Know
finance.yahoo.com - November 11 at 6:52 PM |
| Five Prime Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 11 at 6:52 PM |
| Why This Tiny Biotech Stock More Than Tripled In Bullish Volume
finance.yahoo.com - November 11 at 6:52 PM |
| Five Prime Presents First Preclinical Data on Anti-CCR8 Antibody FPA157
finance.yahoo.com - November 11 at 6:52 PM |
| ROCE Insights For Five Prime Therapeutics
benzinga.com - November 11 at 1:51 PM |
 | Five Prime's Stock Quadruples On Positive Mid-Stage Stomach Cancer Study
msn.com - November 11 at 1:51 PM |
 | Stock Alert: Five Prime Skyrockets 300% On Positive Results From Gastric Cancer Treatment Trial
nasdaq.com - November 11 at 1:51 PM |
|
| Five Prime soars 304% as bemarituzumab + chemo shows significant benefit
seekingalpha.com - November 11 at 8:50 AM |
| Why Five Prime Therapeutics Stock Is on Fire Today
finance.yahoo.com - November 11 at 8:50 AM |
| Five Prime rockets 210% on bemarituzumab data in gastric cancer
seekingalpha.com - November 10 at 7:54 PM |
| Five Prime Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free and Overall Survival Benefit Compared to Placebo Plus Chemotherapy in Front-Line Advanced Gastric and Gastroesophageal Junction Cancer
finance.yahoo.com - November 10 at 7:54 PM |
| Zai Lab Partner Five Prime Therapeutics Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free and Overall Survival Benefit Compared to Placebo Plus Chemotherapy in Front-Line Advanced Gastric or Gastroesophageal Junction Cancer
finance.yahoo.com - November 10 at 7:54 PM |
| Here's What Analysts Are Forecasting For Five Prime Therapeutics, Inc. (NASDAQ:FPRX) After Its Third-Quarter Results
finance.yahoo.com - November 6 at 11:46 AM |
| Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 2:51 AM |
| Five Prime Therapeutics, Inc. (FPRX) CEO Tom Civik on Q3 2020 Results - Quick Version Earnings Call Transcript
seekingalpha.com - November 3 at 9:39 PM |
| Recap: Five Prime Therapeutics Q3 Earnings
finance.yahoo.com - November 3 at 9:39 PM |
| Five Prime Therapeutics (FPRX) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 3 at 9:39 PM |
| Five Prime Therapeutics EPS misses by $0.15, misses on revenue
seekingalpha.com - November 3 at 4:39 PM |
| Five Prime Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - November 3 at 4:39 PM |
| Five Prime Therapeutics Reports Third Quarter 2020 Results
finance.yahoo.com - November 3 at 4:39 PM |
| Five Prime to Present First Preclinical Data of Anti-CCR8 Antibody FPA157 at Society for Immunotherapy of Cancer Virtual Annual Meeting
finance.yahoo.com - November 2 at 10:51 PM |
| Will Five Prime Therapeutics (FPRX) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 28 at 2:43 PM |
| Five Prime Therapeutics Announces Timing of Its Third Quarter 2020 Results Conference Call
finance.yahoo.com - October 27 at 11:24 PM |
| Five Prime (FPRX) Looks Good: Stock Adds 5.1% in Session
nasdaq.com - October 12 at 4:48 PM |
| Five Prime Therapeutics Inc. Re (5P8.SG)
au.finance.yahoo.com - October 9 at 12:43 PM |
| Five Prime Therapeutics, Inc. (FPRX)
finance.yahoo.com - October 1 at 12:00 PM |
| Five Prime Therapeutics (FPRX) Investor Presentation - Slideshow
seekingalpha.com - September 24 at 5:25 PM |
| Benzinga's Top Upgrades, Downgrades For September 22, 2020
finance.yahoo.com - September 22 at 10:41 PM |
